SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of FAYUVI, the first approved treatment for Sanfilippo syndrome Type A, is driving attention, along with the associated Priority Review Voucher and anticipated commercial launch. Traders are broadly bullish on the approval and potential short covering, though some debate the muted share reaction, treatment-label and safety considerations, cash burn, and whether the news is already priced in.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

Concerns that Kalshi, Polymarket and other prediction markets are diverting wagering activity and pressuring DraftKings margins are driving the stock-specific selloff, with traders also pointing to customer-friendly NFL results and promotional spending. The community is divided: bears see worsening competition and profitability risks, while bulls cite DKeX growth and a Ninth Circuit ruling that could strengthen state oversight of rival prediction markets.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Reported insider buying by Ryan Cohen, along with expectations of additional GameStop buybacks, is driving bullish attention as the stock and related warrants rise. Traders are linking the move to elevated borrow costs, options activity and potential short-squeeze pressure, while skeptics point to low volume and the lack of a confirmed new announcement.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is drawing attention after the contested Salad and Go acquisition failed to proceed, with traders linking the sharp selloff and repeated 52-week lows to disappointment over the lost expansion opportunity. The community is split between bears focused on the companys premium valuation, interest rates, competition and consumer spending, and bulls arguing the decline is an overreaction given continued store growth and strong operating performance.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Federal Reserves 25-basis-point rate hike and signal that another increase may follow have made IWM a focal point because small caps are viewed as especially sensitive to borrowing costs and Treasury yields. Traders remain divided between bearish views that higher-for-longer rates will extend the Russell 2000s weakness and expectations for a relief bounce or short-covering rally after the selloff.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of topline Phase 3 APPROACH results for HLP003, with traders citing ahead-of-schedule enrollment, promising earlier-stage data, and recent leadership and insider-buying activity. Sentiment is broadly bullish, though the community remains divided over potential dilution, profit-taking, and the binary risk that Phase 3 results may not meet elevated expectations.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is drawing attention after a sharp rally that has significantly outperformed Bitcoin and other major cryptocurrencies, with traders highlighting its privacy focus, fixed supply and possible short liquidations as drivers. Bullish enthusiasm and FOMO dominate, while skeptics describe the move as speculative and overbought, warning of a potential retracement.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Attention is centered on Ultragenyxs FDA approval of FAYUVI (formerly UX111/ABO-102), an Abeona-originated gene therapy that entitles ABEO to milestone payments and royalties. Traders are debating the financial impact, with optimism over a new revenue stream tempered by concerns about the therapys small rare-disease market and limited peak sales potential.

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Schrodinger Inc

Schrdinger is drawing attention after announcing the formation of Tectora, contributing two early-stage small-molecule programs in exchange for an ownership stake, milestone payments, and royalties. Traders view the capital-light structure positively, while some are speculating about additional partnerships or a potential buyout; those takeover expectations remain unconfirmed.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snaps launch of its Specs augmented-reality glasses and Specs Intelligence AI platform, including enterprise integrations, is driving attention. Traders are split between viewing the technology and partnerships as potentially transformative and arguing that the glasses high cost, uncertain demand, management credibility issues, and repeated sell-the-news pattern are limiting the stocks reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BlackBerry is drawing attention ahead of its scheduled earnings report, with traders positioning for a potential beat and debating whether management will provide stronger growth or Alloy Kore updates. The bullish thesis centers on QNXs role in physical AI and robotics, including its Sift integration for real-time sensor telemetry, while skeptics cite weak revenue growth, management credibility, and the risk of post-earnings selling.

The price move appears tied to increased trading volume and market anticipation surrounding the upcoming earnings report, with some traders citing optimism regarding the company's QNX product demand and long-term electrification trends.

BB Radar Expands Asset Intelligence: New Growth Engine in the Making?

BlackBerry is positioning Radar as an Asset Intelligence Platform, with DCLI's 100,000-chassis deployment showcasing its potential beyond GPS tracking.

Here is What to Know Beyond Why BlackBerry Limited (BB) is a Trending Stock

BlackBerry (BB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

SailPoint, Inc.  (SAIL) Q2 Earnings Surpass Estimates

SailPoint, Inc.  (SAIL) delivered earnings and revenue surprises of +12.50% and -0.51%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

BlackBerry (BB) Increases Despite Market Slip: Here's What You Need to Know

BlackBerry (BB) concluded the recent trading session at $7.87, signifying a +2.21% move from its prior day's close.

The Comeback Story: BlackBerry Limited's (BB) QNX and Growth Potential

The Comeback Story: BlackBerry Limited's (BB) QNX and Growth Potential...

Samsara Inc. (IOT) Surpasses Q2 Earnings and Revenue Estimates

Samsara Inc. (IOT) delivered earnings and revenue surprises of +17.65% and +5.20%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

BlackBerry (BB) Registers a Bigger Fall Than the Market: Important Facts to Note

BlackBerry (BB) concluded the recent trading session at $7.83, signifying a -3.93% move from its prior day's close.

BlackBerry Stock Trending as QNX Expands Into Edge AI With Hailo-8 Support

BlackBerry is trending Friday after its QNX unit announced Thursday support for the Hailo-8 AI Accelerator on QNX SDP 8.0.read more...

The Tech Download: BlackBerry lost the phone war. Now it's betting on cars and robots

BlackBerry CEO John Giamatteo joins CNBC's Arjun Kharpal on The Tech Download podcast...

BB Stock Looks To Reverse 2 Weeks Of Loss: Retail Cheers BlackBerry QNX-Hailo Tie-Up As 'Inflection Point' Ahead Of Earnings

Equity

Retail traders embrace QNX’s Hailo partnership, citing stronger edge AI performance and growth potential in robotics. 


BlackBerry Limited provides intelligent security software and services to enterprises and governments worldwide. The company operates through three segments: Secure Communications, QNX, and Licensing. The company offers BlackBerry Dynamics, a development platform and secure container for mobile applications; BlackBerry Workspaces a secure Enterprise File Sync and Share (EFSS) solution; BlackBerry Messenger (BBM) Enterprise, an enterprise-grade secure instant messaging solution for messaging, voice, and video; BlackBerry SecuSUITE, a multi-OS voice and text messaging solution; BlackBerry AtHoc, a secure networked critical event management solution; and BlackBerry unified endpoint management (UEM) solutions. It also provides BlackBerry Certicom, a patented elliptic curve cryptography, which provides device security, anti-counterfeiting, and product authentication solutions; BlackBerry Radar offers monitoring and telematics solutions for transportation and logistics; and BlackBerry IVY, a vehicle data platform that allows automakers to access vehicle's sensor data and apply machine learning at the edge to generate and share predictive insights and inferences. In addition, the company offers enterprise consulting and engineering consulting services. It is also involved in the patent licensing. The company was formerly known as Research In Motion Limited and changed its name to BlackBerry Limited in July 2013. BlackBerry Limited was incorporated in 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Bullish Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits Polls

Investors are buzzing about the foundational role of QNX as the essential safety-certified software layer for Physical AI, robotics, and edge computing.

High anticipation surrounds the upcoming quarterly earnings, with traders split on whether results will trigger a massive breakout or further capitulation.

Bullish investors are highlighting tight share availability and low volume as potential fuel for a violent squeeze leading into or following the earnings date.

Frustrated long-term holders debate whether the company is truly an undervalued asset with a deep moat or a permanent turnaround-play trap managed by inept leadership.

Some eagle-eyed traders believe repeating '777' block orders on Level 2 screens are a coded market maker signal to support the share price.

Current Price	$7.94
Prev Close	$7.64
Open	$7.84
Dividend Yield	0.00%
50-Day Moving Average	$8.65
Beta	1.53
Avg. Volume	9.73M
PE Ratio	78.52

52-Week High	$13.59
52-Week Low	$3.12
Market Capitalization	$4.48B
EPS (Annual)	$0.089
Price to Book	5.96
Revenue Per Employee	$313,950.83

Feed

News

Sentiment

Earnings

Fundamentals

Info

BB Fundamentals